Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,095 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Geographic disparity of pathophysiological coronary artery disease characteristics: Insights from ASET trials.
Kotoku N, Ninomiya K, Masuda S, Tsai TY, Revaiah PC, Garg S, Kageyama S, Tu S, Kozuma K, Kawashima H, Ishibashi Y, Nakazawa G, Takahashi K, Okamura T, Miyazaki Y, Tateishi H, Nakamura M, Kogame N, Asano T, Nakatani S, Morino Y, Ishida M, Katagiri Y, De Martino F, Tinoco J, Guimarães PO, Tanabe K, Ozaki Y, Muramatsu T, Lemos PA, Onuma Y, Serruys PW; ASET Japan and ASET Brazil Investigators. Kotoku N, et al. Among authors: ozaki y. Int J Cardiol. 2024 Apr 1;400:131805. doi: 10.1016/j.ijcard.2024.131805. Epub 2024 Jan 23. Int J Cardiol. 2024. PMID: 38272132 Free article.
Comparison between optical coherence tomography-guided and intravascular ultrasound-guided primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Matsuwaki Y, Muramatsu T, Ozaki Y, Uwatoko T, Toriya T, Takatsu H, Yoshiki Y, Yoshinaga M, Ishikawa M, Ohota M, Ota H, Izawa H. Matsuwaki Y, et al. Among authors: ozaki y. Fujita Med J. 2024 Feb;10(1):16-23. doi: 10.20407/fmj.2023-006. Epub 2023 Nov 29. Fujita Med J. 2024. PMID: 38332780 Free PMC article.
Prasugrel Monotherapy After Percutaneous Coronary Intervention for Chronic Coronary Syndrome: Insights From ASET Pilot Studies.
Masuda S, Tanabe K, Guimarães PO, Muramatsu T, Ozaki Y, De Martino F, Kozuma K, Garg S, Kotoku N, Ninomiya K, Kageyama S, Lemos PA, Onuma Y, Serruys PW. Masuda S, et al. Among authors: ozaki y. JACC Asia. 2023 Dec 12;4(3):171-182. doi: 10.1016/j.jacasi.2023.10.007. eCollection 2024 Mar. JACC Asia. 2023. PMID: 38463674 Free PMC article.
Frequency of periprocedural myocardial injury and infarction stratified by cardiac troponin I and cardiac troponin T.
Revaiah PC, Tsai TY, Wang B, Renkens M, Kageyama S, Wlodarczak A, Lemoine J, Mollmann H, Sabate M, Sharif F, Zaman A, Wykrzykowska J, Benit E, Qiang HX, Miyashita K, Tobe A, Muramatsu T, Tanabe K, Ozaki Y, Garg S, McEvoy JW, Neumann FJ, Baumbach A, Smits PC, Stone G, Onuma Y, Serruys PW. Revaiah PC, et al. Among authors: ozaki y. Cardiovasc Revasc Med. 2024 May 18:S1553-8389(24)00491-3. doi: 10.1016/j.carrev.2024.05.022. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38789340
Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.
Miyauchi K, Daida H, Morimoto T, Hiro T, Kimura T, Nakagawa Y, Yamagishi M, Ozaki Y, Kadota K, Kimura K, Hirayama A, Kimura K, Hasegawa Y, Uchiyama S, Matsuzaki M; JAPAN-ACS Investigators. Miyauchi K, et al. Among authors: ozaki y. Circ J. 2012;76(4):825-32. doi: 10.1253/circj.cj-12-0135. Circ J. 2012. PMID: 22451449 Free article.
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study.
Isogai A, Nozawa K, Nakakami A, Komaki R, Ozaki Y, Endo Y, Kataoka A, Kotani H, Yoshimura A, Hattori M, Sawaki M, Iwata H. Isogai A, et al. Among authors: ozaki y. Breast Cancer Res Treat. 2024 May 26. doi: 10.1007/s10549-024-07367-x. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 38797792
Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology.
Najima Y, Maeda T, Kamiyama Y, Nakao S, Ozaki Y, Nishio H, Tsuchihashi K, Ichihara E, Miumra Y, Endo M, Maruyama D, Yoshinami T, Susumu N, Takekuma M, Motohashi T, Ito M, Baba E, Ochi N, Kubo T, Uchino K, Kimura T, Tamura S, Nishimoto H, Kato Y, Sato A, Takano T, Yano S. Najima Y, et al. Among authors: ozaki y. Int J Clin Oncol. 2024 May 17. doi: 10.1007/s10147-023-02461-4. Online ahead of print. Int J Clin Oncol. 2024. PMID: 38755516
2,095 results